Albany Molecular Research, Inc. (AMRI) Reports Financial Results for Fourth Quarter of 2008
Albany Molecular Research, Inc. announced that total revenue for the fourth quarter of 2008 was $56.4 million, an increase of $9.2 million or 19%, compared to the fourth quarter of 2007. GAAP net income totaled $3.1 million or $0.10 per basic and diluted share, compared to net loss of ($0.8) million or ($0.03) per basic and diluted share in the fourth quarter of 2007. GAAP net income for the full year of 2008 was $20.6 million or $0.65 per diluted share, compared to net income of $8.9 million or $0.27 per diluted share in the previous year, a 130% increase.…